Vantis Vascular Receives FDA Clearance for 6F CrossFAST Model

RegulatoryapprovedCrossFASTPositive

AI Analysis

Summary

Vantis Vascular received FDA 510(k) clearance for its 6F CrossFAST Model, a new French size variant designed to accommodate a broader range of devices for vascular interventions while maintaining the integrated design features of the original CrossFAST platform.

Outcome Details

FDA 510(k) clearance for 6F CrossFAST Model

Importance:6/10

Sentiment:

0.80

FDA clearance510(k)medical devicesvascularproduct expansion

Related Companies

$INBP $MDCE

Read the original article

Published by PR Newswire Biotech on October 13, 2026 8:10 PM

Read Original